nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Brian Murphy

emeraldbio.life/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Lumentum's OCS & CPO Strength Reflects Broader Demand: What's Ahead?

How Oklo's Nuclear Model Boosts Stability Amid Geopolitical Tensions

Carnival Gains From Strong Onboard Spending: A Yield Driver?

Can Carter's Retail Strength Offset Tariff Pressures in 2026?

Defense Stocks Are Surging and This ETF Lets You Collect Dividends From the Global Arms Race

Capital One Auto's ProtectID Wins 2026 “Fraud Prevention Innovation Award” for its Fraud Protection Tool

L'Oreal: Looking Interesting Again For Long-Term Investors (Upgrade)

FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile

3 Growth ETFs Down This Month and One of Them Is a Buy

Inflation worries tank gold, silver markets

Petrus Resources Ltd. (PRQ:CA) Q4 2025 Earnings Call Transcript

Micron benefits from memory demand

Micron's Insane Growth Doesn't Change Our Bearish Thesis

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

Red Cat Emerges In A High-Growth Market, Time To Ramp Up Production

If you invested $1,000 in Chevron stock at the start of 2026, here's your return now

Stifel Financial: A Wealth Manager's Stock for Wealth Investors

Meta to cut back on third-party vendors in favor of AI for content enforcement

Bronstein, Gewirtz & Grossman LLC Urges Camping World Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges PomDoctor, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

About